Misplaced Pages

Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection. It is taken by mouth.

It was approved for medical use in the United States in November 2019.

References

1. ^ "Talicia- omeprazole magnesium, amoxicillin and rifabutin capsule, delayed release". DailyMed. Retrieved 4 October 2021.
2. "Drug Approval Package: Talicia". U.S. Food and Drug Administration (FDA). 9 April 2020. Retrieved 4 October 2021.

External links

• "Omeprazole". Drug Information Portal. U.S. National Library of Medicine.
• "Amoxicillin". Drug Information Portal. U.S. National Library of Medicine.
• "Rifabutin". Drug Information Portal. U.S. National Library of Medicine.
• Clinical trial number NCT03198507 for "ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator (ERADICATE Hp2)" at ClinicalTrials.gov
• Clinical trial number NCT01980095 for "ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 (ERADICATE Hp)" at ClinicalTrials.gov

• Medicine

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Combination antibiotics
• Helicobacter pylori
• Gastrointestinal system drug stubs
• Antibiotic stubs